Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Turner

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Journal of Neurochemistry|October 23, 2012
Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's diseaseSang-Ho Choi, Saba Aid, Luca Caracciolo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 6, 2022
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodiesFernando L Pagan, Yasar Torres-Yaghi, Michaeline L Hebron, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Intravenous anti-Aβ immunotherapy acutely increases cerebral amyloid angiopathy and vascular damages in APOE4 micePhilip Pikus, Gracie S Healey, Elizabeth Xia, et al.
Neurobiology of Disease|March 6, 2023
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement miceGriffin A Greco, Mitchell Rock, Matthew Amontree, et al.
Journal of Clinical Medicine|June 26, 2025
Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with NilotinibFernando Pagan, Yasar Torres-Yaghi, Michaeline Hebron, et al.
Experimental Neurology|December 10, 2013
A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's diseaseJung Min Song, Amanda Marie DiBattista, You Me Sung, et al.
Neurology|September 13, 2015
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer diseaseR Scott Turner, Ronald G Thomas, Suzanne Craft, et al.
Experimental Neurology|October 16, 2012
Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's diseaseYou Me Sung, Taehee Lee, Hyejin Yoon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2023
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotesMarie-Emmanuelle Riviere, Jessica B Langbaum, R Scott Turner, et al.
Statistics in Medicine|January 13, 2004
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imagingRoger Higdon, Norman L Foster, Robert A Koeppe, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Journal of Neurochemistry|October 23, 2012
Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's diseaseSang-Ho Choi, Saba Aid, Luca Caracciolo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 6, 2022
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodiesFernando L Pagan, Yasar Torres-Yaghi, Michaeline L Hebron, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Intravenous anti-Aβ immunotherapy acutely increases cerebral amyloid angiopathy and vascular damages in APOE4 micePhilip Pikus, Gracie S Healey, Elizabeth Xia, et al.
Neurobiology of Disease|March 6, 2023
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement miceGriffin A Greco, Mitchell Rock, Matthew Amontree, et al.
Journal of Clinical Medicine|June 26, 2025
Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with NilotinibFernando Pagan, Yasar Torres-Yaghi, Michaeline Hebron, et al.
Experimental Neurology|December 10, 2013
A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's diseaseJung Min Song, Amanda Marie DiBattista, You Me Sung, et al.
Neurology|September 13, 2015
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer diseaseR Scott Turner, Ronald G Thomas, Suzanne Craft, et al.
Experimental Neurology|October 16, 2012
Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's diseaseYou Me Sung, Taehee Lee, Hyejin Yoon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2023
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotesMarie-Emmanuelle Riviere, Jessica B Langbaum, R Scott Turner, et al.
Statistics in Medicine|January 13, 2004
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imagingRoger Higdon, Norman L Foster, Robert A Koeppe, et al.
Pageof 7